Greeting from Director
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Stanford Stroke Center, one of the first comprehensive multidisciplinary centers of its kind, was established in 1992 to develop new approaches to diagnose and treat stroke. We assembled a team of neurologists, neurosurgeons, neuroradiologists, nurse specialists, basic scientists, and clinical researchers with the goal of significantly improving the chances that a patient can prevent, or recover optimally, from a stroke.
We are very proud of our accomplishments over the past decade. Stanford is now recognized throughout the world as a leader in stroke research and treatment. The Stanford Stroke Center was ranked the No. 1 academic institution in the country for stroke management by the University Health Consortium. In addition, our group has made the largest number of research contributions to the American Heart Association’s International stroke meeting for each of the last several years.
Stanford has pioneered major advances in medical therapies for treating and preventing stroke, neurosurgical techniques for stroke prevention and exciting interventional neuroradiologic procedures for stroke patients. The Center has provided care for more than 15,000 patients with cerebrovascular disorders. Stanford neuroscientists have helped clarify the basic mechanisms of stroke-induced brain injury and are currently working with several new treatment modalities that offer tremendous promise for the future.
However, despite these accomplishments, stroke continues to be the third leading cause of death and the most common cause of adult disability.More than 750,000 strokes occur in the United States each year; as our population ages, it is estimated that the number of strokes will increase substantially over the next decade. The current window of opportunity for treating most stroke patients is only three hours, which severely limits the number of patients who can be effectively treated. Furthermore, most hospitals are still unequipped to offer state-of-the-art stroke therapies. It is clear that there is still much work left to be done to reduce the burden of stroke in our community.
During our second decade, we hope to broaden the scope of our clinical and basic research activities and to offer new and innovative treatments for our patients.We look forward to working with you to help us meet our goals.
Sincerely,
Gregory W. Albers, MD
Director, Stanford Stroke Center
Professor of Neurology and Neurological Sciences
Stanford University Medical Center
